HIMS News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

HI

Mkt Cap

$6.54B

Volume

9.79M

Next Earnings

November 2nd

Loading chart

HI

HIMSHims & Hers Health, Inc.

HIMS

Pay with—

Available Balance0.00

HI

Mkt Cap

$6.55B

Volume

9.79M

Next Earnings

November 2nd

Chart Financials Earnings News About Insider Filings

ROSEN, LEADING INVESTOR COUNSEL, Encourages Millrose Properties, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRPRosen Law Firm has filed securities class action lawsuits against Millrose Properties, Hims & Hers Health, and Doximity for alleged disclosure failures and misleading statements to investors. Millrose Properties is accused of misrepresenting its business objectives and leasing properties at a loss. Investors have until December 8, 2026 to move the court to serve as lead plaintiff.GlobeNewswire Inc. · Oct 16, 2026

HIMS DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HIMSRosen Law Firm announces a securities class action lawsuit against Hims & Hers Health, Inc. for allegedly making false statements about data privacy practices and billing procedures. The lawsuit claims Hims shared consumer health information with third-party advertisers and charged for prescriptions immediately despite promising consultations with medical providers. Investors who purchased HIMS securities between August 4, 2025 and July 29, 2026 may be eligible for compensation. The lead plaintiff deadline is November 2, 2026.GlobeNewswire Inc. · Oct 16, 2026

Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should KnowHims & Hers Health (HIMS) has attracted investor attention with a 5.3% return over the past month, outperforming the S&P 500. The company shows strong revenue growth of 49.2% year-over-year for the current quarter, but faces challenges with a Zacks Rank #3 (Hold) rating and a D valuation grade indicating premium pricing relative to peers. Earnings estimates remain unchanged over the last 30 days.Zacks Investment Research · Oct 16, 2026

Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor HarmA class action lawsuit has been filed against Hims & Hers Health, Inc. alleging securities fraud. The complaint claims the company made materially false statements regarding data privacy practices, prescription charging procedures, and failed to disclose regulatory scrutiny and potential penalties. Investors who purchased Hims securities between August 4, 2025 and July 29, 2026 are encouraged to join the case, with a lead plaintiff deadline of November 1, 2026.GlobeNewswire Inc. · Oct 16, 2026

INVESTOR DEADLINE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before November 2, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces - HIMSRobbins Geller announces a class action lawsuit against Hims & Hers Health, Inc. for allegedly sharing consumers' health information with third-party advertising platforms and charging for prescriptions immediately after intake forms despite claiming personalized consultations. The FTC filed a lawsuit on July 29, 2026, leading to a 15% decline in Hims & Hers stock. Investors with substantial losses can seek lead plaintiff status before November 2, 2026.GlobeNewswire Inc. · Oct 15, 2026

Robbins LLP Reminds HIMS Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Class ActionRobbins LLP is reminding investors of a pending class action lawsuit against Hims & Hers Health, Inc. for allegedly sharing consumers' sensitive health information with advertising platforms while claiming privacy protection, and engaging in deceptive billing practices. The FTC filed a lawsuit on July 29, 2026, which caused HIMS stock to decline 14.73%. Investors who purchased securities between August 4, 2025 and July 29, 2026 may be eligible to participate, with a lead plaintiff deadline of November 2, 2026.GlobeNewswire Inc. · Oct 14, 2026

Hims & Hers Health, Inc. (HIMS) Suffers a Larger Drop Than the General Market: Key InsightsHims & Hers Health (HIMS) declined 6.7% on October 14, 2026, significantly underperforming the S&P 500's 1.11% loss. Despite a 6.68% monthly gain, the stock faces upcoming earnings on November 9, 2026, with expectations of $0.07 EPS (up 16.67% YoY) and $893.37M revenue (up 49.15% YoY). The company holds a Zacks Rank #3 (Hold) rating with stagnant consensus estimates.Zacks Investment Research · Oct 14, 2026

Deadline Alert: Hims & Hers Health, Inc. (HIMS) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud LawsuitA class action securities fraud lawsuit has been filed against Hims & Hers Health, Inc. following an FTC lawsuit alleging the telehealth provider shared consumers' sensitive health information with third-party advertising platforms and engaged in deceptive billing practices. The stock declined 14.73% on July 29, 2026, following the FTC announcement. Investors who purchased HIMS securities between August 4, 2025 and July 29, 2026 have until November 2, 2026 to file a lead plaintiff motion.GlobeNewswire Inc. · Oct 14, 2026

Hims & Hers Expands Australian Women's Health Platform With HersHims & Hers Health has launched Hers, its women's health platform, in Australia by rebranding Juniper from its Eucalyptus acquisition. The platform offers personalized care for hair regrowth, menopause, and weight management with 24/7 support. The expansion leverages Eucalyptus' local presence to strengthen brand recognition and recurring revenue in the growing Australian telehealth market, which is projected to grow at 18.2% CAGR through 2034.Zacks Investment Research · Oct 14, 2026

HIMS DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HIMSRosen Law Firm has filed securities class action lawsuits against multiple companies. The primary case involves Hims & Hers Health, Inc., alleging the company made false statements about data privacy, charged consumers for prescriptions without proper consultation, and failed to disclose regulatory scrutiny. The firm is seeking lead plaintiffs with a November 2, 2026 deadline. Similar lawsuits have been filed against Papa John's International and Millrose Properties.GlobeNewswire Inc. · Oct 14, 2026

to start trading

HI

HIMSHims & Hers Health, Inc.

HIMS

Pay with—

Available Balance0.00

Your PositionYou don't own any HIMS yet.

Related Tickers

Earnings